Scott Nicholas Furlan, MD

On staff since December 2015

Academic Title: Acting Instructor

"I am driven to improve the therapy of cancer and blood disorders in children not only with thoughtful research, but also by accompanying patients and their families through the daily triumphs and struggles of their journey, one-by-one."

Patient Testimonials
Be the first to recommend Dr. Scott Nicholas Furlan
Publications
Other Publications

Furlan SN, Watkins B, Tkachev V, Flynn R, Cooley S, Ramakrishnan S, Singh K, Giver C, Hamby K, Stempora L, Garrett A, Chen J, Betz KM, Ziegler CG, Tharp GK, Bosinger SE, Promislow DE, Miller JS, Waller EK, Blazar BR, Kean LS
Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.
26606970 Science translational medicine, 2015 Nov. 25 : 7(315)315ra191

Furlan SN, Mandraju R, Brewer T, Roybal K, Troutman TD, Hu W, Palm NW, Unni A, Pasare C
Enhancement of anti-tumor CD8 immunity by IgG1-mediated targeting of Fc receptors.
24284965 mAbs, 2014 Jan. : 6(1)108-18 PMCID:PMC3929435
Show More Hide

Overview

Board Certification(s): Pediatrics
Pediatric Hematology-Oncology
Pediatrics
Pediatric Hematology-Oncology
Medical/Professional School: Keck School of Medicine at USC, Los Angeles
Keck School of Medicine at USC, Los Angeles
Residency: Pediatrics, UT Southwestern Medical School, Dallas
Pediatrics, UT Southwestern Medical School, Dallas
Fellowship: Pediatric Hematology-Oncology, UT Southwestern Medical Center, Dallas
Seattle Children's Research Institute, Seattle
Pediatric Hematology-Oncology, UT Southwestern Medical Center, Dallas
Seattle Children's Research Institute, Seattle
Clinical Interests: Hematopoietic cell transplantation, graft-versus-host disease, transplant immunology, cellular therapies
Research Description: Genomics, immunology, molecular biology